Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.

The Pharma 50 has a new company sitting at the top: Eli Lilly, which last year was in the ninth slot. The next question is how long it can stay there, because pharma sector leadership is, historically, something of a revolving door. Right now, Lilly’s lead is razor thin. Just $170 million separated Eli Lilly’s… The post Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that. appeared first on Drug Discovery and Development.

Continue reading →